BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38521179)

  • 21. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
    Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
    Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
    [No Abstract]   [Full Text] [Related]  

  • 22. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
    Tao S; Cui D; Cheng H; Liu X; Jiang Z; Chen H; Gao Y
    BMC Cancer; 2024 Feb; 24(1):194. PubMed ID: 38347489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.
    Liu M; Jiang K; Lin G; Liu P; Yan Y; Ye T; Yao G; Barr MP; Liang D; Wang Y; Gong P; Meng S; Piao H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):165. PubMed ID: 30041665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
    Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
    Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.
    Guo X; Wang Z; Deng X; Lu Y; Huang X; Lin J; Lan X; Su Q; Wang C
    Cell Cycle; 2022 Aug; 21(15):1557-1577. PubMed ID: 35400275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
    Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
    Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
    Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
    J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis.
    Tang J; Long G; Li X; Zhou L; Zhou Y; Wu Z
    Cell Commun Signal; 2023 Aug; 21(1):198. PubMed ID: 37559097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation.
    Hoshino K; Nakazawa S; Yokobori T; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Harimoto N; Tokunaga F; Shirabe K
    Sci Rep; 2024 Jan; 14(1):346. PubMed ID: 38172174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RING-finger protein 5 promotes hepatocellular carcinoma progression and predicts poor prognosis.
    Zhang Y; Li J; Chen H; Zhang C; You S; Zhao Y; Lin X; Yu Y; Fang F; Fang T; Wang X
    Hum Cell; 2021 Mar; 34(2):530-538. PubMed ID: 33469898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
    Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
    Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
    Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
    Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.
    Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J
    Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
    Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
    Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.